-

Valor Compounding Pharmacy Featured in Business Journals Nationwide

Valor is one of the top-ranked privately held companies, two years in a row, as named by Inc. 5000

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy is featured in The Business Journals, discussing how they maintain a patient care promise for customer satisfaction and trust as the focus of the business. In addition to this feature, Valor is named by Inc. 5000 as one of the Fastest-Growing Private Companies in America 2021.

Being honored two years in a row by Inc. 5000 is a key recognition that Valor Compounding Pharmacy is easy to work with and actively refines customer and patient experiences. Valor is continually growing to expand treatment options to meet patient expectations with service areas across the United States.

It is easy to Get Started with Valor for patients or physicians, as well as Telehealth companies.

Read the feature in The Business Journals here. See Valor Compounding Pharmacy’s ranking on the Inc. 5000 list of Fastest-Growing Private Companies in America 2021 here.

About Valor Compounding Pharmacy:

Valor Compounding Pharmacy™, Inc. is a multi-state licensed 503A facility housing both sterile and non-sterile laboratories, located in Berkeley, CA. PCAB accredited, Valor is a specialized pharmacy that makes custom medications to meet the unique needs of the individual patient. Our goal is to reinvent pharmacy from a reactive vendor to a proactive partner in patient health care. We do that by optimizing turnaround time, being data-driven, and reducing patient anxiety. Our focus is on non-sterile and sterile, hazardous and non-hazardous compounded medication, and we work with a network of providers, patients, health systems/institutions, and research scientists in multiple states in the United States.

About The Business Journals:

The Business Journal’s 40 business newspapers stretch from Washington, D.C., to San Francisco, and from Austin, Texas, to Albany, N.Y. BizJournals features local people and decision makers who are leaders in their business communities. They report on local and national issues that impact subscribers’ businesses and assist them in growing their companies.

Contacts

Valor Compounding Pharmacy
Marketing & Media
Lucy Casey
510.603.4799
marketing@vcprx.com

Valor Compounding Pharmacy


Release Summary
The Business Journals is featuring Valor's accomplishments, including Valor's Inc 5000 nomination, for the second year in a row.
Release Versions

Contacts

Valor Compounding Pharmacy
Marketing & Media
Lucy Casey
510.603.4799
marketing@vcprx.com

More News From Valor Compounding Pharmacy

As Health Systems Rethink In-House Compounding, Valor Compounding Pharmacy Highlights How Outsourcing Low-Volume Prescriptions Saves Risk, Time, and Money

BERKELEY, Calif.--(BUSINESS WIRE)--As healthcare systems face increasing regulatory scrutiny and financial pressure, many are re-evaluating the value of maintaining in-house compounding operations for outpatient prescriptions. The reality: compounded medications serve a very small percentage of the patient population, yet require disproportionately high investment, compliance oversight, and staff time to sustain safety. Valor Compounding Pharmacy, a multi-state licensed 503a pharmacy headquarte...

Valor Compounding Pharmacy Announces Call for New Partnerships with Medical Practices and Hospital Systems

BERKELEY, Calif.--(BUSINESS WIRE)--Valor is a specialized pharmacy that prepares custom medications to meet the unique needs of the individual patient....

2022 Year-in-Review with Valor Compounding Pharmacy

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy closes the year achieving growth in multiple areas throughout its business while continuing to exceed customer satisfaction standards. Valor has expanded its state-of-the-art 503A facility that holds both sterile and non-sterile laboratories to a 6,421 square feet workspace to support its growing customer demand. After completing the expansion in the 3rd quarter of 2022, the compounding pharmacy relaunched its sterile operations, hav...
Back to Newsroom